Willingness versus ability to pay for drugs in the US

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.376, 2002-01, pp. : 9-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Willingness-to-pay a better measure to value drugs?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 609, 2010-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Questioning willingness to pay

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 592, 2009-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Willingness to Pay for Cancer Prevention

By Hunt Timothy L.

PharmacoEconomics, Vol. 27, Iss. 4, 2009-06 ,pp. : 299-312

Adis International

Access to resources Recommend Favorite

Economic Evaluation of Insulin Lispro versus Neutral (Regular) Insulin Therapy Using a Willingness-To-Pay Approach

By Davey P.

PharmacoEconomics, Vol. 13, Iss. 3, 1998-03 ,pp. : 347-358

Adis International

Access to resources Recommend Favorite

Conjoint Analysis of a New Chemotherapy: Willingness to Pay and Preference for the Features of Raltitrexed versus Standard Therapy in Advanced Colorectal Cancer

By Aristides M.

PharmacoEconomics, Vol. 20, Iss. 11, 2002-01 ,pp. : 775-784

Adis International

Access to resources Recommend Favorite